Patient Experience With Later Line Chemotherapy in Four Tumor Types

    May 2026 in “ Journal of Clinical Oncology ”
    Patricia Dorling, Alexandra Kissling, E Mulvihill … Daphne Derose
    Studysummary In this study, patients with advanced cancers reported significant quality of life impacts from second-line therapies, including gastrointestinal and neurological side effects, emotional distress, and social isolation, yet remained motivated to continue treatment for survival and personal connections.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →